SCPHARMACEUTICALS INC. Deferred Tax Assets, Gross
SCPHARMACEUTICALS INC. had Deferred Tax Assets, Gross of $94.43 million as of 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2025-03-19
- 2024-12-31: Deferred Tax Assets, Gross $94.43M.
- 2023-12-31: Deferred Tax Assets, Gross $74.34M.
- 2022-12-31: Deferred Tax Assets, Gross $59.50M.
- 2021-12-31: Deferred Tax Assets, Gross $51.51M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2024-12-31 | $94.43M 10-K · filed 2025-03-19 |
| 2023-12-31 | $74.34M 10-K · filed 2025-03-19 |
| 2022-12-31 | $59.50M 10-K · filed 2024-03-13 |
| 2021-12-31 | $51.51M 10-K · filed 2023-03-22 |
| 2020-12-31 | $43.42M 10-K · filed 2022-03-22 |
| 2019-12-31 | $34.33M 10-K · filed 2021-03-23 |
| 2018-12-31 | $24.71M 10-K · filed 2020-03-24 |
| 2017-12-31 | $16.65M 10-K · filed 2019-03-21 |